Mediclinic Group is aware of a fake social media post that is being circulated requesting users to engage with a Medical Feedback Reward Survey. Mediclinic has not circulated any such survey. The social media post has not been published by Mediclinic. Mediclinic advises that people do not engage with the survey or respond. We release all our official communications on our website and our official social media channels which are listed on the website’s footer.
Dr. Ayman El-Hattab has the American Board in Pediatrics, the American Board of Clinical Genetics, and the American Board of Biochemical Genetics (Metabolic); he is also a fellow member of the American Academy of Pediatrics (AAP) and the American College of Medical Genetics (ACMG).
Dr. Ayman El-Hattab has more than 15 years of experience in the field of genetics. He has worked at Baylor College of Medicine and University of Missouri in USA, King Fahad Medical City in Saudi Arabia, and he has been working in several hospitals in United Arab Emirates.
Dr. Ayman El-Hattab sees children and adults with confirmed or suspected genetic diseases including children with developmental delay, cognitive impairment, autism, congenital anomalies, growth failure, metabolic diseases and chromosomal and genetic syndromes. He also sees people with variable genetic diseases including cardiac (e.g. cardiomyopathies and arrhythmias), neurologic (e.g. muscle dystrophies and neuropathies), endocrine (e.g. growth hormone deficiency and monogenic diabetes), renal (e.g. malformation and congenital nephrotic syndromes), dermatology (e.g. ichthyosis and epidermolysis bullosa), eye (e.g. retinitis pigmentosa and optic atrophy), and inherited hearing impairment. In addition, people with personal or family history of cancer are seen to be evaluated for inherited cancer syndrome. Genetic screening for inherited diseases is also performed for couples planning to have children.
Dr. Ayman El-Hattab is a Professor at the College of Medicine, University of Sharjah and he is heavily involved in research. He has conducted many clinical research projects, and he has more than 120 publications, several book chapters, and many presentations in scientific conferences. His research fields include chromosomal abnormalities, metabolic disorders, neurogenetic diseases, novel gene and syndrome discovery, and mitochondrial diseases. Professor Ayman El-Hattab has received several awards, and he was designated as one of the world’s top 2% scientists in the field of genetics by Stanford University, USA in a report published in October 2020.
